argenx SE | Investor Conference Presentation Deck | 27 slides · page 8 of 27
The slide highlights clinical outcomes (QoL, MG-ADL scores), treatment protocols (steroid tapering), patient support (My VYVGART Path), and economic value (cost/benefit vs IVIg).
Conference presentation · key_takeaways · summarize · dense density
Slide locked Sign in to view
Slide schematic 7/7
list 4/4 paragraph 1/1 source-note 1/1 title 1/1
Components 7
bullet bullet bullet bullet paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.